2 Grants
2022
Development of BBB-permeable SUMO1 small molecule degraders for glioblastoma therapy.
Hao, Chunhai C and Hamdouchi, Chafiq
National Institutes of Health (NIH), National Institute of Neurological Disorders and Stroke (NINDS) (ID: 1R01NS126358-01), $474,563USD, 2022-03-01 -- 2027-02-28
 
Development of SUMO1 small molecule degraders as the first-in-class anticancerdrugs for metastatic colorectal cancer
Bellail, Anita⋅Hao, Chunhai C and Hamdouchi, Chafiq
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 1R44CA265547-01A1), $1,019,583USD, 2022-07-01 -- 2024-06-30